Fujita H, Okamoto M, Takao A, Mase H, Kojima H
Dept. of Bacteriology, School of Dental Medicine, Tsurumi University.
Gan To Kagaku Ryoho. 1994 Apr;21(5):653-8.
The plasma disposition of paclitaxel in rabbits (7 mg/kg, 1 h i.v. inf.) was biphasic with half-lives of 0.36 and 6.36 h, and AUC was 9.46 micrograms.hr/ml. K12 value was larger than K21 and V2 was larger than V1, suggesting that paclitaxel had a favorable distribution profile in tissues. In S 180 bearing male ICR mice (30 mg/kg, i.v. bolus), the biphasic plasma disposition was also observed. The half-lives and AUC were 0.25 h, 2.23 h and 117.93 micrograms.hr/ml. Paclitaxel distributed widely in plasma rather than blood cells. The biliary level of paclitaxel in the enlarged gallbladder of ICR mice was markedly high, about 10-fold higher than the urinary level and 100-fold higher than the plasma level. The bioavailability with oral administration to ICR mice was poor. AUC(oral)/AUC(i.v.) ratio in the bile, liver, tumor and plasma was 18.91, 6.71, 0.83 and 0.45%, respectively.
紫杉醇在兔体内(7毫克/千克,静脉滴注1小时)的血浆处置呈双相性,半衰期分别为0.36小时和6.36小时,曲线下面积(AUC)为9.46微克·小时/毫升。K12值大于K21,V2大于V1,表明紫杉醇在组织中具有良好的分布特征。在接种S 180的雄性ICR小鼠(30毫克/千克,静脉推注)中,也观察到了双相性血浆处置。半衰期和AUC分别为0.25小时、2.23小时和117.93微克·小时/毫升。紫杉醇广泛分布于血浆而非血细胞中。ICR小鼠胆囊增大时,胆汁中紫杉醇水平明显较高,约为尿液水平的10倍,血浆水平的100倍。ICR小鼠口服给药的生物利用度较差。胆汁、肝脏、肿瘤和血浆中的AUC(口服)/AUC(静脉注射)比值分别为18.91%、6.71%、0.83%和0.45%。